VSPR SEC filings, in plain English
Everything Vesper Healthcare Acquisition Corp. has filed with the SEC that we hold — 40 filings, newest first, 7 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: SkinHealth Systems Inc. (Nasdaq: SKIN) reported that on August 10, 2026 Sheri Lewis notified the company of her decision to resign as Chief Operations, Quality and Technology Officer to pursue other business opportunities outside the company, ceasing to serve in that role effective August 28, 2026. The filing states the resignation is not the result of any disagreement with the company, its board or management on any matter relating to operations, policies or practices. Why it matters: A named executive officer departure with a stated effective date and the standard no-disagreement representation; the filing discloses no successor, no severance arrangement and no interim assignment of the role.
What changed: DEF 14A of SkinHealth Systems Inc. calling a virtual special meeting of stockholders for September 22, 2026 at 8:00 a.m. Pacific Time, with a record date of August 3, 2026 and proxy materials first made available on or about August 12, 2026. Proposal 1 asks stockholders to approve an amendment to the Restated Certificate of Incorporation combining outstanding Class A common stock into a lesser number of shares at a ratio of not less than 1-for-5 and not more than 1-for-20, with the exact ratio to be set within that range by the board in its sole discretion. Why it matters: The reverse split is proposed, not effected, and the ratio is a range the board would choose within — no specific ratio, effective date or resulting share count is stated in the notice.
What changed: SkinHealth Systems Inc. (Nasdaq: SKIN) filed as additional definitive proxy materials the notice card for a special stockholders meeting to be held virtually on September 22, 2026 at 8:00 a.m. PDT, with voting closing at 11:59 p.m. ET on September 21, 2026 and paper or email copies of materials available on request until September 8, 2026. Why it matters: The vote grants a range rather than a ratio — the board would choose anywhere from 1-for-5 to 1-for-20 afterwards, so approving it does not fix how many shares a holder ends up with. Nothing in this notice states a purpose for the split or a deadline by which it must be effected.
What changed: SkinHealth Systems Inc. (Nasdaq: SKIN), which the release identifies as home to the Hydrafacial brand, furnished a press release reporting second quarter 2026 results. Net sales were $72.1 million, down 7.8%, with Delivery Systems at $18.3 million against $22.4 million and Consumables at $53.9 million against $55.8 million; 770 delivery systems were placed against 957, while the active install base rose to 36,516 from 35,193. Why it matters: System placements fell 20% while the install base grew 4%, so consumables revenue — 75% of the total — is being carried by a base that is still expanding even as new placements shrink. Third quarter net sales guidance of $65 to $70 million is below the $72.1 million just delivered, and moving two more markets to distributors removes direct revenue from the reported line.
What changed: The 10-Q filed under Commission file number 001-39565 is that of SkinHealth Systems Inc. (Nasdaq: SKIN) for the quarter ended June 30, 2026, with 130,140,763 Class A shares outstanding as of August 3, 2026. Net sales were $72,113 thousand against $78,187 thousand a year earlier and $137,023 thousand for the six months against $147,767 thousand, while operating expenses fell to $45,766 thousand from $51,812 thousand, turning a $2,700 thousand operating loss into $3,572 thousand of operating income. Why it matters: $345.2 million of convertible senior notes stand against $206.1 million of cash, and $103.1 million of them is now current — the near-term maturity is larger than half the cash balance. Sales fell 8% while operating expense fell 12%, which is what turned the operating line positive; the swing to a net loss is interest cost and the absence of a prior-year gain.
What changed: SkinHealth Systems Inc., the successor to Vesper Healthcare Acquisition Corp., filed a preliminary proxy for a virtual special meeting on September 22, 2026 at 8:00 a.m. Pacific Time, with an August 3, 2026 record date and internet proxies due September 21, 2026. Proposal No. 1 is a reverse stock split of the Class A common stock and Proposal No. 2 is an adjournment proposal for insufficient votes or quorum. The stated primary objective is to raise the per-share trading price to meet the Nasdaq Capital Market continued listing requirement of a bid price of at least $1.00 per share. Why it matters: This is a listing-defense vote: the company says outright that the split exists to get the Class A bid price back over the Nasdaq $1.00 minimum, after the bid had sat below a dollar for 30 consecutive business days and with the stock at $0.6986. A preliminary filing also means the definitive proxy and the final split ratio are still to come, so the exact exchange ratio is not yet fixed, and the adjournment proposal signals management expects turnout to be tight.
What changed: SkinHealth Systems Inc., formerly known as The Beauty Health Company and the successor to Vesper Healthcare Acquisition Corp., called its annual meeting for June 10, 2026 at 1:00 p.m. Pacific Time as a completely virtual meeting at virtualshareholdermeeting.com/SKIN2026, record date April 16, 2026, with each share of Class A Common Stock entitled to one vote. The letter is signed by Pedro Malha as President and Chief Executive Officer. The Insider Trading Policy is filed as Exhibit 19.1 to the Annual Report on Form 10-K filed with the SEC on March 12, 2026. Why it matters: The rebranding from The Beauty Health Company to SkinHealth Systems, disclosed here alongside a new CEO signing the stockholder letter, marks a full repositioning of the business the Vesper SPAC took public - a reset rather than continuity. No trust or redemption right survives for legacy SPAC holders, so the equity now depends entirely on whether the renamed operating company can execute; the proxy itself puts no financing or dilution item to a vote.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.